Markets

Insider Trading

Hedge Funds

Retirement

Opinion

13 Best Growth Stocks Under $50 to Buy Now

In this article, we will look at the 13 Best Growth Stocks Under $50 to Buy Now.

On September 8, Scott Chronert, Citi U.S. equity strategist, appeared on CNBC’s ‘The Exchange’ to talk about the current market environment, amongst other things.

His concern, for some time now, has been the notion that as we move further and further away from the pandemic episode, the broader consumption pictures are appearing as a “pretty big issue” and a potential headwind.

READ ALSO: 10 Best Airport and Air Services Stocks to Buy and 12 Best Waste Management Stocks to Buy Right Now.

In these circumstances, he stated that he thinks at some point one needs to see the Fed moving toward Fed neutral, which kind of came out in Chairman Powell’s talk at Jackson Hole. The inflation data, according to him, does not reflect what we would normally think of an overheated economic situation.

Chronert further stated that according to him, we are looking at ongoing transitory inflation effects that ultimately say “hey look, we’re okay on the earnings picture here.”

With these trends in view, let’s look at the best growth stocks under $50 to buy now.

Our Methodology

We used stock screeners to compile a list of top growth stocks with a stock price under $50 and chose the top 13 most popular among hedge funds as of Q2 2025. We sourced the hedge fund sentiment data from Insider Monkey’s database. The list is sorted in ascending order of hedge fund holders.

Note: All data was sourced on September 8.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

13 Best Growth Stocks Under $50 to Buy Now

13. Enbridge Inc. (NYSE:ENB)

Stock Price: $48.26

Number of Hedge Fund Holders: 30

Enbridge Inc. (NYSE:ENB) is one of the best growth stocks under $50 to buy now. Barclays analyst Theresa Chen maintained a Hold rating on Enbridge Inc. (NYSE:ENB) on September 3, setting a price target of C$65.00.

Enbridge Inc. (NYSE:ENB) announced on September 2 that it reached a final investment decision on two attractive Gas Transmission projects. It signed a commercial agreement for the Algonquin Reliable Affordable Resilient Enhancement project (AGT Enhancement).

Management reported that this is anticipated to raise deliveries on Algonquin Gas Transmission pipeline to existing Local Distribution Company (LDC) customers in the US Northeast.

Enbridge Inc. (NYSE:ENB) further reported that through its Matterhorn joint venture, it made a final investment decision on the Eiger Express Pipeline (Eiger), which is “an up to 2.5 billion cubic feet per day (Bcf/d) pipeline from the Permian Basin to the Katy area to serve the growing U.S. Gulf Coast LNG market.”

Enbridge Inc. (NYSE:ENB) provides gas and oil. The company’s operations are divided into the following segments: Liquid Pipelines, Gas Distribution and Storage, Gas Transmission and Midstream, Renewable Power Generation, and Energy Services.

12. Infosys (NYSE:INFY)

Stock Price: $16.38

Number of Hedge Fund Holders: 30

Infosys (NYSE:INFY) is one of the best growth stocks under $50 to buy now. In a report released on September 3, Harry Read from Redburn Atlantic initiated coverage on Infosys (NYSE:INFY) with a Sell rating and a price target of $12.00.

In other news, Infosys (NYSE:INFY) announced a multi-year strategic collaboration with One Bright Kobe on September 2. One Bright Kobe operates Glion Arena Kobe, which is a new multi-purpose arena in Kobe, Japan.

Management reported that as part of the collaboration, Infosys (NYSE:INFY) would be Glion Arena Kobe’s Official Digital Innovation and GX (Green Transformation) partner.

The “strategic engagement” with Japan’s first entertainment arena, according to the company, is set to “revolutionize live entertainment and sports through advanced digital innovation and sustainable practices,” ushering in “a new era for live events” by leveraging the power of Infosys Cobalt.

Infosys Cobalt is a set of solutions, services, and platforms for enterprises to accelerate their cloud journey.

Infosys (NYSE:INFY) is a digital services and consulting company that provides end-to-end business solutions. The company’s operations are divided into the following segments: Financial Services, Retail, Communication; Energy, Utilities, Resources, and Services; Manufacturing, Hi-Tech, Life Sciences, and All Other.

11. GSK plc (NYSE:GSK)

Stock Price: $40.50

Number of Hedge Fund Holders: 36

GSK plc (NYSE:GSK) is one of the best growth stocks under $50 to buy now. In a report released on September 4, David Evans from Kepler Capital maintained a Hold rating on GSK plc (NYSE:GSK), setting a price target of p1,500.00.

GSK plc (NYSE:GSK) released its fiscal Q2 2025 earnings on July 30, reporting total sales of £8.0 billion. Total operating profit for the quarter rose 33% while total EPS increased by 35%, driven by lower CCL charges.

GSK plc (NYSE:GSK) also reported £2.4 billion in cash generated from operations, with free cash flow of £1.1 billion.

Formerly known as GlaxoSmithKline, GSK plc (NYSE:GSK) is a global healthcare and biopharmaceutical corporation that develops and distributes a range of vaccines, medications, and consumer health items. It is based in the United Kingdom and has over 20 vaccines in its portfolio, positioning it as a leader in vaccines, immunology, and respiratory therapies. The company also develops cancer treatments for multiple myeloma, ovarian cancer, and endometrial cancer in addition to other drugs.

10. Samsara Inc. (NYSE:IOT)

Stock Price: $42.09

Number of Hedge Fund Holders: 41

Samsara Inc. (NYSE:IOT) is one of the best growth stocks under $50 to buy now. On September 8, Morgan Stanley raised the firm’s price target on Samsara Inc. (NYSE:IOT) to $53 from $50, keeping an Equal Weight rating on the shares.

The firm told investors that net new ARR rose by 19% year-over-year in Q2 in constant currency, rising meaningfully from 7% in Q1. It, however, added that the sustainability of this growth will be “the main question going forward.”

Samsara Inc. (NYSE:IOT) develops internet-connected sensor systems, combining wireless connectivity, plug-and-play sensors, and cloud-hosted software integrated for deployment. The company offers AI-powered safety programs that train and protect employees.

9. Super Micro Computer Inc. (NASDAQ:SMCI)

Stock Price: $40.41

Number of Hedge Fund Holders: 48

Super Micro Computer Inc. (NASDAQ:SMCI) is one of the best growth stocks under $50 to buy now. On September 4, Citi analyst Asiya Merchant maintained a Hold rating on Super Micro Computer Inc. (NASDAQ:SMCI) and set a price target of $48.00.

Super Micro Computer Inc. (NASDAQ:SMCI) reported its fiscal Q4 2025 earnings on August 5, announcing net sales of $5.8 billion compared to $4.6 billion in fiscal Q3 2025 and $5.4 billion in fiscal Q4 2024.

Net income for the quarter reached $195 million compared to $109 million in the previous quarter, while cash flow provided by operations was $864 million.

Super Micro Computer Inc. (NASDAQ:SMCI) distributes and manufactures information technology solutions and other computer products. The company’s products include GPU and coprocessors, twin solutions, MicroCloud, MP servers, AMD solutions, power supplies, SuperServer, motherboards, storage, and more.

8. On Semiconductor Corporation (NASDAQ:ON)

Stock Price: $49.10

Number of Hedge Fund Holders: 50

On Semiconductor Corporation (NASDAQ:ON) is one of the best growth stocks under $50 to buy now. On September 8, TD Cowen analyst Joshua Buchalter maintained a Buy rating on On Semiconductor Corporation (NASDAQ:ON) and set a price target of $55.00.

On Semiconductor Corporation (NASDAQ:ON) announced its fiscal Q2 2025 results on August 4, reporting $1.468 billion in revenue, cash from operations of $184.3 million, and free cash flow of $106.1 million.

GAAP operating margin and non-GAAP operating margin for the quarter were 13.2% and 17.3%, respectively.

On Semiconductor Corporation (NASDAQ:ON) provides intelligent power and sensing solutions with a primary focus on industrial and automotive markets. The company’s operations are divided into the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG).

7. Teva Pharmaceutical Industries Limited (NYSE:TEVA)

Stock Price: $18.95

Number of Hedge Fund Holders: 57

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best growth stocks under $50 to buy now. On September 5, J.P. Morgan analyst Chris Schott maintained a Buy rating on Teva Pharmaceutical Industries Limited (NYSE:TEVA) and set a price target of $23.00.

On August 28, Teva Pharmaceutical Industries Limited (NYSE:TEVA) announced the FDA approval and U.S. launch of Generic Saxenda, the first-ever generic GLP-1 indicated for weight loss, targeting the rising demand for this category of therapies in the US market.

Management reported that the Liraglutide injection is indicated for “adults with obesity or overweight (excess weight) who also have weight-related medical problems, and pediatric patients (12-17 years) with a weight greater than 60 kg and obesity to help them lose weight and keep the weight off.”

Teva Pharmaceutical Industries Limited (NYSE:TEVA) develops, produces, and sells medicines. Its operations are divided into the US, Europe, and International Markets geographical segments.

Each business segment covers the entire product portfolio in that region, including specialty, generics, and over-the-counter (OTC) products.

6. Grab Holdings Limited (NASDAQ:GRAB)

Stock Price: $5.16

Number of Hedge Fund Holders: 60

Grab Holdings Limited (NASDAQ:GRAB) is one of the best growth stocks under $50 to buy now. On August 4, Morgan Stanley analyst Divya Gangahar maintained a Buy rating on Grab Holdings Limited (NASDAQ:GRAB), retaining the price target of $6.05.

Venugopal Garre from Bernstein also expressed bullish sentiments for the stock on August 1, giving Grab Holdings Limited (NASDAQ:GRAB) a Buy rating with a price target of $5.60.

The same day, Mizuho Securities also maintained a Buy rating on Grab Holdings Limited (NASDAQ:GRAB), setting a $6.00 price target.

Currently, the analyst consensus on Grab Holdings Limited (NASDAQ:GRAB) is a Strong Buy, with the stock’s median price target of $5.20 implying an upside of 15.50% from current levels.

Grab Holdings Limited (NASDAQ:GRAB) provides millions of consumers access to its merchant and driver partners for food delivery, ride or taxi hailing, package delivery, payment for online purchases, and services such as telemedicine, lending, and insurance through its application. The company’s operations across mobility, deliveries, and digital financial services span eight Southeast Asian countries.

5. Hewlett Packard Enterprise Company (NYSE:HPE)

Stock Price: $23.52

Number of Hedge Fund Holders: 60

Hewlett Packard Enterprise Company (NYSE:HPE) is one of the best growth stocks under $50 to buy now. In a report released on September 5, Samik Chatterjee from J.P. Morgan maintained a Buy rating on Hewlett Packard Enterprise Company (NYSE:HPE) and set a price target of $30.00.

Hewlett Packard Enterprise Company (NYSE:HPE) reported its fiscal Q3 2025 results on September 3, reporting a revenue of $9.1 billion, up 19% from the prior-year period in actual dollars and 18% in constant currency.

The annualized revenue run-rate (ARR) for the quarter reached $3.1 billion, reflecting 77% growth from the prior-year period in actual dollars and 75% in constant currency.

Management also reported that free cash flow rose $121 million from the prior-year period to $790 million, while capital returns to common shareholders were $171 million in the form of dividends.

Hewlett Packard Enterprise Company (NYSE:HPE) is a global edge-to-cloud company that delivers open and intelligent technology solutions as a service. The company offers compute, cloud services, intelligent edge, high-performance computing & artificial intelligence, software, and storage.

Its operations are divided into the Server, Hybrid Cloud, Intelligent Edge, Financial Services, and Corporate Investments and Other segments.

4. Toast, Inc. (NYSE:TOST)

Stock Price: $41.22

Number of Hedge Fund Holders: 67

Toast, Inc. (NYSE:TOST) is one of the best growth stocks under $50 to buy now. In a report released on August 13, Dominick Gabriele from Compass Point maintained a Buy rating on Toast, Inc. (NYSE:TOST) with a price target of $52.00.

Similarly, UBS analyst Timothy Chiodo also maintained a Buy rating on the stock on August 7, setting a price target of $55.00.

In another report released on August 6, Needham also reiterated bullish sentiments for Toast, Inc. (NYSE:TOST) and set a $60.00 price target.

Toast, Inc. (NYSE:TOST) has a consensus rating of Moderate Buy, and its median price target of $40.38 implies an upside of 26.30% from current levels.

Toast, Inc. (NYSE:TOST) develops and provides consumer payment applications for restaurants, offering kiosks, terminals, guest-facing displays, and system accessories. The company’s offerings also include reporting and analytics, point of sale, kitchen display system, and online ordering and delivery.

3. Bristol-Myers Squibb Company (NYSE:BMY)

Stock Price: $47.14

Number of Hedge Fund Holders: 67

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best growth stocks under $50 to buy now. On September 8, BMO Capital analyst Evan Seigerman maintained a Hold rating on Bristol-Myers Squibb Company (NYSE:BMY), retaining the price target of $47.00.

The analyst attributed the rating to the performance of Cobenfy, the company’s new product, in the market, stating that its growth has been stable with a modest percentage increase in the weekly prescription rates.

However, he added that the growth failed to meet the levels expected by some investors for H2 2025. The revenue estimates for the product in Q3 fall slightly below consensus estimates, supporting the Hold rating.

Bristol-Myers Squibb Company (NYSE:BMY) is a biopharmaceutical company that discovers, develops, and delivers advanced medicines for serious diseases. Its medicines fall into various therapeutic classes, including hematology, oncology, cardiovascular, immunology, and neuroscience.

2. Intel Corporation (NASDAQ:INTC)

Stock Price: $24.49

Number of Hedge Fund Holders: 82

Intel Corporation (NASDAQ:INTC) is one of the best growth stocks under $50 to buy now. On September 4, Citi analyst Christopher Danely reiterated a Hold rating on Intel Corporation (NASDAQ:INTC) and set a $24.00 price target.

The analyst supported the optimistic rating with the company’s product development timelines and strategic partnerships, stating that a primary factor is the collaboration between Intel Corporation (NASDAQ:INTC) and the US government.

He stated that the partnership would act as a silent partner without affecting company decisions and is regarded as a stable support for the company’s future prospects.

Danely added that while Intel Corporation’s (NASDAQ:INTC) technological advancements (such as the 18A process node and Panther Lake CPU) are progressing as planned, the company’s profitability remains below the average trading range of semiconductor companies, warranting a cautious outlook.

Intel Corporation (NASDAQ:INTC) designs, manufactures, and sells computer products and technologies, delivering data storage, computer, networking, and communications platforms. The company’s operations are divided into the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other.

1. Pfizer Inc. (NYSE:PFE)

Stock Price: $24.88

Number of Hedge Fund Holders: 83

Pfizer Inc. (NYSE:PFE) is one of the best growth stocks under $50 to buy now. On September 8, Pfizer Inc. (NYSE:PFE) and BioNTech SE announced positive topline results from an ongoing Phase 3 clinical trial cohort “evaluating the safety, tolerability, and immunogenicity of a 30-µg dose of the LP.8.1-adapted monovalent COMIRNATY® 2025-2026 Formula in adults aged 65 and older and in adults aged 18 through 64 with at least one underlying risk condition for severe COVID-19.”

Management reported that the preliminary data exhibited considerable growth in neutralizing antibodies targeting the LP.8.1 sublineage of SARS-CoV-2 after the vaccination, reinforcing pre-clinical data that supported the recent U.S. Food and Drug Administration (FDA) approval of the LP.8.1-adapted COVID-19 vaccine demonstrating improved immune responses against multiple circulating SARS-CoV-2 sublineages.

Pfizer Inc. (NYSE:PFE) also reported that the vaccine’s safety profile was consistent with previous studies, and no new safety concerns were identified.

Pfizer Inc. (NYSE:PFE) is a global biopharmaceutical company that manufactures, develops, markets, and sells biopharmaceutical products worldwide. It advances wellness, prevention, treatment, and cures in developing and emerging markets.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.